BDX · NYSE · CIK 0000010795
BECTON DICKINSON & CO
BECTON DICKINSON & CO’s most recent SEC filing in our snapshot is a Form 4 filed on Oct 27, 2026. In fiscal 2025 (year ended Sep 30, 2025) it reported revenue of $21.8B and net income of $1.7B, according to its XBRL data on EDGAR. Its EDGAR record lists 67 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- BECTON DICKINSON & CO
- Ticker
- BDX
- SEC Central Index Key (CIK)
- 0000010795
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus (code 3841)
- Business address
- FRANKLIN LAKES, NJ
- State or country of incorporation
- NJ
- Fiscal year ends
- September 30
- SEC filer category
- Large accelerated filer
- Position in SEC ticker list
- #301 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from BECTON DICKINSON & CO’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Sep 30, 2021 | FY2022 ended Sep 30, 2022 | FY2023 ended Sep 30, 2023 | FY2024 ended Sep 30, 2024 | FY2025 ended Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $19.1B | $18.9B | $19.4B | $20.2B | $21.8B |
| Net income | $2.1B | $1.8B | $1.5B | $1.7B | $1.7B |
| Diluted EPS | $6.85 | $5.88 | $4.94 | $5.86 | $5.82 |
| Total assets | $53.9B | $52.9B | $52.8B | $57.3B | $55.3B |
| Cash and equivalents | $2.3B | $1.0B | $1.4B | $1.7B | $641.0M |
XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Nov 25, 2025 | 10-K | Annual report· period Sep 30, 2025 | Document · Index |
| Aug 6, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 6, 2026 | 8-K | Results of operations· period Aug 6, 2026 | Document · Index |
| Dec 18, 2025 | DEF 14A | Definitive proxy statement· period Dec 12, 2025 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about BECTON DICKINSON & CO, by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 27, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Oct 26, 2026 | Document · Index |
| Oct 26, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Sep 29, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 28, 2026 | Document · Index |
| Sep 28, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Sep 3, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 2, 2026 | Document · Index |
| Aug 27, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 26, 2026 | Document · Index |
| Aug 26, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 24, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 20, 2026 | Document · Index |
| Aug 20, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 14, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 13, 2026 | Document · Index |
| Aug 13, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 11, 2026 | Document · Index |
| Aug 11, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 7, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Aug 6, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 6, 2026 | Document · Index |
| Aug 6, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 6, 2026 | Document · Index |
| Aug 6, 2026 | 8-K | Results of operations· period Aug 6, 2026 | Document · Index |
| Aug 6, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Aug 6, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 3, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jul 28, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 27, 2026 | Document · Index |
| Jul 27, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jul 22, 2026 | 8-K | Director or officer change; Regulation FD disclosure· period Jul 19, 2026 | Document · Index |
| Jul 6, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 1, 2026 | Document · Index |
| Jun 29, 2026 | 11-K | Annual report of employee stock plans· period Dec 31, 2025 | Document · Index |
| Jun 29, 2026 | 11-K | Annual report of employee stock plans· period Dec 31, 2025 | Document · Index |
| Jun 26, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jun 26, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 26, 2026 | Document · Index |
| Jun 25, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 24, 2026 | Document · Index |
| Jun 24, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jun 22, 2026 | 3 | Initial statement of beneficial ownership· period Jun 22, 2026 | Document · Index |
| Jun 11, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026 | Document · Index |
| Jun 10, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jun 4, 2026 | 25-NSE | 25-NSE | Document · Index |
| Jun 3, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026 | Document · Index |
| Jun 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026 | Document · Index |
| Jun 2, 2026 | 3 | Initial statement of beneficial ownership· period Jun 1, 2026 | Document · Index |
| Jun 1, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| May 29, 2026 | 8-K | Regulation FD disclosure· period May 29, 2026 | Document · Index |
| May 27, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 26, 2026 | Document · Index |
Insider filing activity
67 Form 4 filings appear in BECTON DICKINSON & CO’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Surgical & Medical Instruments & Apparatus
- SYK STRYKER CORP
- MMM 3M CO
- BSX BOSTON SCIENTIFIC CORP
- MDLN Medline Inc.
- RMD RESMED INC
- DXCM DEXCOM INC
- WST WEST PHARMACEUTICAL SERVICES INC
- SOLV Solventum Corp
All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in New Jersey
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000010795 and XBRL company facts. BECTON DICKINSON & CO on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement